Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TOCILIZUMAB vs TOFERSEN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

TOCILIZUMAB vs TOFERSEN: Safety Overview

Metric TOCILIZUMAB TOFERSEN
Total FAERS Reports 98,443 366
Deaths Reported 9,543 60
Death Rate 9.7% 16.4%
Hospitalizations 24,039 97
Average Patient Age 52.2 yrs 56.9 yrs
% Female Patients 84.5% 48.3%
FDA Approval Date N/A Apr 25, 2023
Manufacturer CELLTRION USA, Inc. Biogen Inc.
Route INTRAVENOUS INTRATHECAL
Marketing Status Prescription Prescription